R. Bryan Barriger

1.9k total citations · 1 hit paper
19 papers, 1.4k citations indexed

About

R. Bryan Barriger is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, R. Bryan Barriger has authored 19 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiation and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in R. Bryan Barriger's work include Lung Cancer Diagnosis and Treatment (15 papers), Advanced Radiotherapy Techniques (10 papers) and Lung Cancer Treatments and Mutations (8 papers). R. Bryan Barriger is often cited by papers focused on Lung Cancer Diagnosis and Treatment (15 papers), Advanced Radiotherapy Techniques (10 papers) and Lung Cancer Treatments and Mutations (8 papers). R. Bryan Barriger collaborates with scholars based in United States, Canada and Spain. R. Bryan Barriger's co-authors include Achilles J. Fakiris, Jeffrey D. Bradley, David A. Palma, Lawrence B. Marks, George Rodrigues, Marta Moreno, Suresh Senan, Sara Ramella, Tae Hyun Kim and Ramesh Rengan and has published in prestigious journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

R. Bryan Barriger

17 papers receiving 1.4k citations

Hit Papers

Predicting Radiation Pneumonitis After Chemoradiation The... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Bryan Barriger United States 10 1.2k 715 651 214 174 19 1.4k
Anders Traberg Denmark 7 873 0.7× 717 1.0× 423 0.6× 267 1.2× 91 0.5× 7 1.2k
Lena Wittgren Sweden 11 1.1k 0.9× 933 1.3× 658 1.0× 129 0.6× 117 0.7× 13 1.4k
Berit Wennberg Sweden 16 1.1k 0.9× 1.0k 1.4× 741 1.1× 184 0.9× 194 1.1× 22 1.5k
Jana Fox United States 15 644 0.5× 494 0.7× 450 0.7× 246 1.1× 151 0.9× 42 1.1k
Merete Paludan Denmark 9 987 0.8× 804 1.1× 466 0.7× 137 0.6× 117 0.7× 13 1.3k
Yoshiki Norihisa Japan 17 1.4k 1.2× 1.2k 1.6× 733 1.1× 142 0.7× 122 0.7× 44 1.7k
Melenda Jeter United States 21 1.2k 1.0× 612 0.9× 481 0.7× 357 1.7× 95 0.5× 50 1.6k
Alessia Guarneri Italy 15 794 0.7× 559 0.8× 377 0.6× 154 0.7× 51 0.3× 43 1.0k
J. DeLuca United States 6 1.2k 1.0× 962 1.3× 504 0.8× 170 0.8× 145 0.8× 8 1.5k
Joern Wulf Germany 12 953 0.8× 1.1k 1.5× 605 0.9× 132 0.6× 44 0.3× 16 1.3k

Countries citing papers authored by R. Bryan Barriger

Since Specialization
Citations

This map shows the geographic impact of R. Bryan Barriger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Bryan Barriger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Bryan Barriger more than expected).

Fields of papers citing papers by R. Bryan Barriger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Bryan Barriger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Bryan Barriger. The network helps show where R. Bryan Barriger may publish in the future.

Co-authorship network of co-authors of R. Bryan Barriger

This figure shows the co-authorship network connecting the top 25 collaborators of R. Bryan Barriger. A scholar is included among the top collaborators of R. Bryan Barriger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Bryan Barriger. R. Bryan Barriger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Willers, Henning, Thomas E. Stinchcombe, R. Bryan Barriger, et al.. (2015). ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer. American Journal of Clinical Oncology. 38(2). 197–205. 7 indexed citations
3.
Stanic, Sinisa, Rebecca Paulus, Robert Timmerman, et al.. (2014). No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy for Early- Stage Peripheral Non-Small Cell Lung Cancer: An Analysis of RTOG 0236. International Journal of Radiation Oncology*Biology*Physics. 88(5). 1092–1099. 113 indexed citations
4.
Chang, Joe Y., Larry L. Kestin, R. Bryan Barriger, et al.. (2014). ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent.. PubMed. 28(8). 706–10, 712, 714 passim. 24 indexed citations
5.
Timmerman, Robert, Chen Hu, Jeff M. Michalski, et al.. (2014). Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 90(1). S30–S30. 154 indexed citations
6.
Palma, David A., Suresh Senan, Kayoko Tsujino, et al.. (2013). Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis. International Journal of Radiation Oncology*Biology*Physics. 85(2). 444–450. 482 indexed citations breakdown →
7.
Palma, David A., Suresh Senan, Cary Oberije, et al.. (2013). Predicting Esophagitis After Chemoradiation Therapy for Non-Small Cell Lung Cancer: An Individual Patient Data Meta-Analysis. International Journal of Radiation Oncology*Biology*Physics. 87(4). 690–696. 135 indexed citations
8.
Palma, David A., Suresh Senan, Cary Oberije, et al.. (2013). Predicting Esophagitis After Chemoradiation Therapy for Non-Small Cell Lung Cancer: An Individual Patient Data Meta-Analysis of >1000 Patients. International Journal of Radiation Oncology*Biology*Physics. 87(2). S3–S4. 1 indexed citations
9.
Varlotto, John M., Achilles J. Fakiris, John C. Flíckinger, et al.. (2013). Matched‐pair and propensity score comparisons of outcomes of patients with clinical stage I non–small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer. 119(15). 2683–2691. 80 indexed citations
10.
Willers, Henning, Thomas E. Stinchcombe, Joe Y. Chang, et al.. (2013). INDUCTION AND ADJUVANT THERAPY FOR N2 NON-SMALL-CELL LUNG CANCER.
11.
Palma, David A., Suresh Senan, Kayoko Tsujino, et al.. (2012). Predicting Symptomatic Radiation Pneumonitis After Concurrent Chemoradiation Therapy for Non-small Cell Lung Cancer: Results of an International Individual Patient Data Meta-analysis. International Journal of Radiation Oncology*Biology*Physics. 84(3). S549–S549. 3 indexed citations
12.
Stanic, Sinisa, Rebecca Paulus, Robert Timmerman, et al.. (2012). No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy (SBRT) Among Medically Inoperable Patients With Early Stage Peripheral Non-small Cell Lung Cancer: An Analysis of RTOG 0236. International Journal of Radiation Oncology*Biology*Physics. 84(3). S48–S48. 4 indexed citations
13.
Andolino, David L., Jeffrey A. Forquer, M. Henderson, et al.. (2011). Chest Wall Toxicity After Stereotactic Body Radiotherapy for Malignant Lesions of the Lung and Liver. International Journal of Radiation Oncology*Biology*Physics. 80(3). 692–697. 88 indexed citations
14.
Barriger, R. Bryan, Andrew L. Chang, Simon S. Lo, et al.. (2011). Phosphorus-32 therapy for cystic craniopharyngiomas. Radiotherapy and Oncology. 98(2). 207–212. 37 indexed citations
15.
Barriger, R. Bryan, et al.. (2010). Dose–Volume Analysis of Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated With Concurrent Cisplatinum and Etoposide With or Without Consolidation Docetaxel. International Journal of Radiation Oncology*Biology*Physics. 78(5). 1381–1386. 74 indexed citations
16.
Barriger, R. Bryan, Jeffrey A. Forquer, Jeffrey G. Brabham, et al.. (2010). A Dose–Volume Analysis of Radiation Pneumonitis in Non–Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 82(1). 457–462. 202 indexed citations
17.
Barriger, R. Bryan, et al.. (2009). Treatment of anal carcinoma in immune-compromised patients. Clinical & Translational Oncology. 11(9). 609–614. 5 indexed citations
18.
Andolino, David L., Jeffrey A. Forquer, M. Henderson, et al.. (2009). Maximum Dose to Chest Wall Greater than 60 Gy and Volume of Chest Wall Receiving Greater than 30 Gy Predict Risk of Chest Wall Toxicity following Stereotactic Body Radiation Therapy (SBRT). International Journal of Radiation Oncology*Biology*Physics. 75(3). S60–S60. 4 indexed citations
19.
Barriger, R. Bryan, Menggang Yu, Craig H. Reynolds, et al.. (2008). Rates and Risk of Pneumonitis in Non-small Cell Lung Carcinoma (NSCLC) Patients (pts) Treated with Concurrent Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 72(1). S117–S118. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026